CTI Life Sciences Fund
Finance · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Place Ville-Marie Suite 1050, Montreal...Phone Number
(514) 798-2333Website
www.ctisciences.comRevenue
$5.3 MillionIndustry
About CTI Life Sciences Fund
CTI Life Sciences Fund is a prominent Canadian biotech venture capital firm that focuses on catalyzing innovative ideas and assets into scalable biotech companies. With over 20 years in business, the firm has made more than 30 investments across various therapeutic modalities, emphasizing both long-term value creation and expedited exit strategies. Their portfolio includes companies developing groundbreaking treatments in areas such as oncology, cardiology, and rare diseases. CTI aims to deliver life-saving therapies while generating returns for their investors and fostering growth in the local innovation ecosystem.Explore more
CTI Life Sciences Fund Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to CTI Life Sciences Fund
Compare insights from companies similar to CTI Life Sciences Fund, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CTI Life Sciences Fund Tech Stack
A closer look at the technologies used by CTI Life Sciences Fund
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CTI Life Sciences Fund
Sign Up For FreeTo access detailed company insights
CTI Life Sciences Fund is a prominent Canadian biotech venture capital firm that focuses on catalyzing innovative ideas and assets into scalable biotech companies. With over 20 years in business, the firm has made more than 30 investments across various therapeutic modalities, emphasizing both long-term value creation and expedited exit strategies.... Read More
